Does recombinant human erythropoietin administration in critically ill COVID‐19 patients have miraculous therapeutic effects?-Reference-Cited by-同舟云学术

Does recombinant human erythropoietin administration in critically ill COVID‐19 patients have miraculous therapeutic effects?

Published:2020-04-19 Issue:7 Volume:92 Page:915-918
ISSN:0146-6615
Container-title:Journal of Medical Virology
language:en
Short-container-title:J Med Virol

Author:

Hadadi Azar¹^ORCID,Mortezazadeh Masoud²^ORCID,Kolahdouzan Kasra³^ORCID,Alavian Golbarg⁴

Affiliation:

1. Department of Infectious Diseases, Sina HospitalTehran University of Medical Sciences Tehran Iran

2. Internal Medicine DepartmentTehran University of Medical Sciences Tehran Iran

3. Radiation Oncology DepartmentCancer Institute, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences Tehran Iran

4. Pharmacotherapy Department, Faculty of PharmacyTehran University of Medical Sciences Tehran Iran

Publisher

Wiley

Subject

Infectious Diseases,Virology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jmv.25839

Reference18 articles.

1. World Health OrganizationAvailable from:www.who.int

2. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China;Wu C;JAMA Intern Med,2020

3. Erythropoietin and Nonhematopoietic Effects

4. Erythropoietin in Critical Illness and Trauma

5. Protective effects of erythropoietin towards acute lung injuries in rats with sepsis and its related mechanisms;Zhang X;Ann Clin Lab Sci,2019

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Deciphering the similarities and disparities of molecular mechanisms behind respiratory epithelium response to HCoV-229E and SARS-CoV-2 and drug repurposing, a systems biology approach;DARU Journal of Pharmaceutical Sciences;2024-04-23

2. Why have SGLT2 Inhibitors Failed to Achieve the Desired Success in COVID-19?;Current Pharmaceutical Design;2024-04

3. Precision nutrition to reset virus-induced human metabolic reprogramming and dysregulation (HMRD) in long-COVID;npj Science of Food;2024-03-30

4. Targeting 2-Oxoglutarate–Dependent Dioxygenases Promotes Metabolic Reprogramming That Protects against Lethal SARS-CoV-2 Infection in the K18-hACE2 Transgenic Mouse Model;ImmunoHorizons;2023-07-01

5. Deferoxamine has the Potential to Improve the COVID-19-Related Inflammatory Response in Diabetic Patients;International Journal of Peptide Research and Therapeutics;2023-05-30